FDA panel will hold a public hearing on orphan-drug research

06/28/2010 | Reuters

An FDA committee will hold a two-day public hearing this week to discuss strategies that would encourage drugmakers to develop treatments for rare diseases. The meeting comes after the FDA released a list of approved medicines that could be used for orphan-drug research.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR